Abstract

A total of 62 Prototheca bovis isolates from cases of bovine mastitis were tested for susceptibility to different antifungal compounds by the Clinical and Laboratory Standards Institute (CLSI) reference microdilution method and a commercial colorimetric microdilution panel (Sensititre YeastOne). All isolates displayed low susceptibility to echinocandins (MICs > 8 mu g/ml for anidulafungin, caspofungin, and micafungin), flucytosine (MIC > 64 mu g/ml), and the azoles enilconazole and fluconazole (MICs > 4 and > 64 mu g/ml, respectively). Moreover, 45.2, 32.3, and 1.6% of isolates had MICs> 4 mu g/ml for ketoconazole, terbinafine, and voriconazole, respectively, when tested by the CLSI method. In contrast, all isolates were more susceptible to the polyene compounds amphotericin B and nystatin, and itraconazole, posaconazole, and ravuconazole (MICs
Loading...

Quotes

0 citations in WOS
0 citations in

Journal Title

Journal ISSN

Volume Title

Publisher

Oxford University Press

Description

Citation

Alvarez-Perez, Sergio; Anega, Blanca; Diaz-de-Tuesta, Juan A; Gonzalez-Martin, Juan, V; Riesgo-Martinez, Mercedes; Garcia, Marta E; Blanco, Jose L (2021). Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel. Medical Mycology, 59(12), 1257-1261. DOI: 10.1093/mmy/myab063

Endorsement

Review

Supplemented By

Referenced By

Statistics

Views
4
Downloads
8

Bibliographic managers

Document viewer

Select a file to preview:
Reload